These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2658786)

  • 1. Effects of beta-lactamases and omp mutation on susceptibility to beta-lactam antibiotics in Escherichia coli.
    Hiraoka M; Okamoto R; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Mar; 33(3):382-6. PubMed ID: 2658786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
    Jacoby GA; Carreras I
    Antimicrob Agents Chemother; 1990 May; 34(5):858-62. PubMed ID: 2193623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of methoxy-substitution of beta-lactam compounds on the interaction with various beta-lactamases.
    Cullmann W; Dick W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Nov; 256(1):109-18. PubMed ID: 6362278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.
    Takahashi I; Sawai T; Ando T; Yamagishi S
    J Antibiot (Tokyo); 1980 Sep; 33(9):1037-42. PubMed ID: 7002896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.
    Gazouli M; Tzouvelekis LS; Vatopoulos AC; Tzelepi E
    J Antimicrob Chemother; 1998 Oct; 42(4):419-25. PubMed ID: 9818739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. False extended-spectrum {beta}-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins.
    Beceiro A; Maharjan S; Gaulton T; Doumith M; Soares NC; Dhanji H; Warner M; Doyle M; Hickey M; Downie G; Bou G; Livermore DM; Woodford N
    J Antimicrob Chemother; 2011 Sep; 66(9):2006-10. PubMed ID: 21742679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics.
    Bradford PA; Sanders CC
    Antimicrob Agents Chemother; 1995 Feb; 39(2):308-13. PubMed ID: 7726487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
    Sakurai Y; Yoshida Y; Saitoh K; Nemoto M; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1990 Apr; 43(4):403-10. PubMed ID: 2112533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multifactorial analysis of the phenotypes for beta-lactams of 1044 Escherichia coli strains].
    Chardon H; Fosse T; Labia R; Nicolas MH; Poyart-Salmeron C; Sirot J; Sirot D; Veron M
    Pathol Biol (Paris); 1993 Apr; 41(4):337-42. PubMed ID: 8233632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
    Medeiros AA; Hare R; Papa E; Adam C; Miller GH
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the substrate spectrum by an amino acid substitution at residue 219 in the Citrobacter freundii cephalosporinase.
    Tsukamoto K; Ohno R; Sawai T
    J Bacteriol; 1990 Aug; 172(8):4348-51. PubMed ID: 2115867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Lactamases and beta-lactam resistance in Escherichia coli.
    Jacoby GA; Sutton L
    Antimicrob Agents Chemother; 1985 Nov; 28(5):703-5. PubMed ID: 3911882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactamase stability of cefoxitin in comparison with other beta-lactam compounds.
    Neu HC
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):313-6. PubMed ID: 6321094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surveillance of Pseudomonas aeruginosa sensitivity to antibiotics in France and distribution of beta-lactam resistance mechanisms: 1998 GERPB study].
    Cavallo JD; Leblanc F; Fabre R
    Pathol Biol (Paris); 2000 Jun; 48(5):472-7. PubMed ID: 10949844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations affecting the resistance of Escherichia coli K-12 to beta-lactam antibiotics.
    Hrebenda J; Heleszko H
    J Antimicrob Chemother; 1985 Aug; 16(2):149-56. PubMed ID: 3905746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
    Hashizume T; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.